• Profile
Close

Assessing antiretroviral use during gaps in HIV primary care using multisite Medicaid claims and clinical data

Journal of Acquired Immune Deficiency Syndromes Aug 17, 2017

Monroe AK, et al. – Authors aimed at assessing antiretroviral use during gaps in HIV primary care using multisite Medicaid claims and clinical data. Medicaid–insured individuals commonly receive antiretroviral therapy (ART) during gaps in HIV primary care, but almost half do not. Retention measures based on visit frequency data that do not incorporate receipt of ART and/or viral suppression may misclassify individuals who remain suppressed on ART as not retained.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay